| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Changing frontline AML treatment patterns from 2013 to 2022
|
Brandwein, Joseph M.
|
|
|
132 |
C |
p.
|
artikel
|
| 2 |
Cohesin complex mutations in myeloid neoplasms are enriched for SRSF2, RUNX1, TET2, and NRAS co-mutations and morphologic dysplasia
|
Hirt, Christian K.
|
|
|
132 |
C |
p.
|
artikel
|
| 3 |
Corrigendum to “Diagnostic performance of F-18 FDG PET/CT in the detection of bone marrow involvement in paediatric hodgkin lymphoma: A meta-analysis” [Leuk. Res. 102 (2021) 106525]
|
Kim, Keunyoung
|
|
|
132 |
C |
p.
|
artikel
|
| 4 |
Economic burden during remission and after relapse among older patients with newly diagnosed acute myeloid leukemia without hematopoietic stem cell transplant: A retrospective study using the SEER-Medicare database
|
Brunner, Andrew M.
|
|
|
132 |
C |
p.
|
artikel
|
| 5 |
Editorial Board
|
|
|
|
132 |
C |
p.
|
artikel
|
| 6 |
FLAG based v/s Standard 3 + 7 induction therapy in treatment naïve Acute Myeloid Leukemia: Time to think “beyond anthracyclines”
|
Shaikh, Mohd Rizwan
|
|
|
132 |
C |
p.
|
artikel
|
| 7 |
FOXK2 regulates PFKFB3 in promoting glycolysis and tumorigenesis in multiple myeloma
|
Liu, Xinling
|
|
|
132 |
C |
p.
|
artikel
|
| 8 |
Germline predisposition to clonal hematopoiesis
|
Liu, Jie
|
|
|
132 |
C |
p.
|
artikel
|
| 9 |
Hyperleukocytosis in patients with acute myeloid leukemia admitted to the intensive care unit: a single-center retrospective analysis
|
Heger, Jan-Michel
|
|
|
132 |
C |
p.
|
artikel
|
| 10 |
Incidence and predictors of anthracycline-related left ventricular dysfunction in acute myeloid leukemia
|
Stahl, Maximilian
|
|
|
132 |
C |
p.
|
artikel
|
| 11 |
MiR-409–3p regulates the proliferation and apoptosis of THP-1 through targeting Rab10
|
Xie, Wenjie
|
|
|
132 |
C |
p.
|
artikel
|
| 12 |
mRNA-1273 SARS-CoV-2 vaccine in recently transplanted allogeneic hematopoietic cell transplant recipients: Dynamics of cellular and humoral immune responses and booster effect
|
Albiol, Nil
|
|
|
132 |
C |
p.
|
artikel
|
| 13 |
Re-induction with venetoclax combinations or IDH inhibitors result in similar remission rates and lower treatment related morbidity among AML patients initially receiving intensive induction chemotherapy
|
Taylor, Skyler
|
|
|
132 |
C |
p.
|
artikel
|
| 14 |
The presence of additional cytogenetic aberrations in chronic myeloid leukemia cells at the time of diagnosis or their appearance on tyrosine kinase inhibitor therapy predicts the imatinib treatment failure
|
Ratajczak, Błażej
|
|
|
132 |
C |
p.
|
artikel
|
Tijdschrift beschrijving